We are live on ! Find out more
CSS

Cubist Systematic Strategies Portfolio holdings

AUM $21B
1-Year Est. Return 21.48%
This Fund
S&P 500
This Quarter Est. Return
-4.64%
1 Year Est. Return
+21.48%
3 Year Est. Return
+78.34%
5 Year Est. Return
+110.56%
10 Year Est. Return
+239.04%
AUM
$11.8B
AUM Growth
+$1.34B
Cap. Flow
+$2.18B
Cap. Flow %
18.39%
Top 10 Hldgs %
3.51%
Holding
4,052
New
613
Increased
1,643
Reduced
1,246
Closed
518

Top Buys

Rank Stock Value
1
ABT icon
Abbott
ABT
+$34.6M
2
WDAY icon
Workday
WDAY
+$33.5M
3
FRC
First Republic Bank
FRC
+$31.8M
4
ZTS icon
Zoetis
ZTS
+$31.3M
5
SYF icon
Synchrony
SYF
+$31M

Top Sells

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$35.7M
2
HON icon
Honeywell
HON
+$31.7M
3
IP icon
International Paper
IP
+$30.5M
4
ADM icon
Archer Daniels Midland
ADM
+$23.8M
5
EMR icon
Emerson Electric
EMR
+$22.5M

Sector Composition

Rank Sector Weight
1 Technology 18.12%
2 Financials 17.75%
3 Healthcare 12.17%
4 Consumer Discretionary 11.8%
5 Industrials 11.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
INVZ icon
3326
Innoviz Technologies
INVZ
$114M
$66K ﹤0.01%
18,166
-126,012
-87% -$504K
PL icon
3327
Planet Labs
PL
$8.23B
$66K ﹤0.01%
13,031
-37,992
-74% -$209K
DOUG icon
3328
Douglas Elliman
DOUG
$166M
$65K ﹤0.01%
9,375
-43,280
-82% -$328K
OUST icon
3329
Ouster
OUST
$3.04B
$65K ﹤0.01%
1,448
-1,066
-42% -$39.3K
IRNT
3330
DELISTED
IronNet, Inc.
IRNT
$65K ﹤0.01%
+17,022
New +$66.8K
HEXO
3331
DELISTED
HEXO Corp. Common Shares
HEXO
$65K ﹤0.01%
7,487
-5,671
-43% -$48.3K
APN.WS
3332
DELISTED
Apeiron Capital Investment Corp. Redeemable Warrants
APN.WS
$65K ﹤0.01%
+384,100
New +$114K
NGNE icon
3333
Neurogene
NGNE
$729M
$64K ﹤0.01%
1,715
+751
+78% +$43.8K
OSUR icon
3334
OraSure Technologies
OSUR
$276M
$64K ﹤0.01%
+9,400
New +$75.1K
NAGE
3335
Niagen Bioscience
NAGE
$241M
$64K ﹤0.01%
+26,123
New +$71.4K
FATH
3336
DELISTED
Fathom Digital Manufacturing Corporation
FATH
$64K ﹤0.01%
+515
New +$83.6K
APEN
3337
DELISTED
Apollo Endosurgery, Inc.
APEN
$63K ﹤0.01%
10,400
-20,745
-67% -$126K
ALDX icon
3338
Aldeyra Therapeutics
ALDX
$91.1M
$62K ﹤0.01%
13,985
-70,357
-83% -$280K
XOS icon
3339
Xos
XOS
$37M
$62K ﹤0.01%
690
-2,377
-78% -$179K
ITAQW
3340
DELISTED
Industrial Tech Acquisitions II, Inc. Warrants
ITAQW
$62K ﹤0.01%
+249,599
New +$56.7K
BIOSW
3341
DELISTED
BioPlus Acquisition Corp. Warrants
BIOSW
$62K ﹤0.01%
+269,683
New +$70K
TLGYW
3342
DELISTED
TLGY Acquisition Corporation Warrant
TLGYW
$62K ﹤0.01%
+321,788
New +$78.8K
NCMI icon
3343
National CineMedia
NCMI
$370M
$61K ﹤0.01%
+2,410
New +$67.1K
BBAR icon
3344
BBVA Argentina
BBAR
$3.53B
$60K ﹤0.01%
+16,764
New +$54.6K
ZUMZ icon
3345
Zumiez
ZUMZ
$330M
$60K ﹤0.01%
1,583
-30,761
-95% -$1.34M
FRLAW
3346
DELISTED
Fortune Rise Acquisition Corporation Warrant
FRLAW
$60K ﹤0.01%
+239,448
New +$69.9K
BCEL
3347
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$60K ﹤0.01%
19,084
-19,638
-51% -$47.6K
ACRS icon
3348
Aclaris Therapeutics
ACRS
$868M
$59K ﹤0.01%
3,429
-17,583
-84% -$240K
THC icon
3349
Tenet Healthcare
THC
$20.9B
$59K ﹤0.01%
690
-26,648
-97% -$2.19M
CRON
3350
Cronos Group
CRON
$1.11B
$58K ﹤0.01%
14,800
-15,100
-51% -$55K
132 133
134
135 136

Similar funds

GIM
Glenmede Investment Management Philadelphia, Pennsylvania $20.7B AUM
ECM
Eisler Capital Management London, United Kingdom $22.6B AUM 9.36% 1-Year Est. Return
JFL
Jarislowsky, Fraser Ltd Montreal, Quebec, Canada $18.2B AUM 22.04% 1-Year Est. Return
BAM
Burgundy Asset Management Toronto, Ontario, Canada $10.6B AUM 13.39% 1-Year Est. Return
SF
Synovus Financial Columbus, Georgia $8.74B AUM 12.78% 1-Year Est. Return
WIM
Waverton Investment Management London, United Kingdom $7.77B AUM 25.07% 1-Year Est. Return
AIM
AXA Investment Managers Puteaux, France $37.1B AUM
SIG
Stonegate Investment Group Birmingham, Alabama $4.31B AUM 18.07% 1-Year Est. Return

Cubist Systematic Strategies's Q1 2022 Portfolio in Review

As of Q1 2022, Cubist Systematic Strategies held 4,052 positions worth $11.8B, up 13% from $10.5B the previous quarter. Its ten largest holdings account for 3.5% of the portfolio.

Cubist Systematic Strategies deployed $2.18B of net new capital in Q1 2022, opening 613 new positions and adding to 1,643 existing holdings. Its largest new stake was Trine II Acquisition Corp.: 2,018,590 shares worth $20.1M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Medtronic, an estimated $35.7M trimmed.

  • Cubist Systematic Strategies's largest Q1 2022 buy was Trine II Acquisition Corp.: 2,018,590 shares worth $20.1M.
  • Cubist Systematic Strategies added most to Abbott in Q1 2022, an estimated $34.6M increase.
  • Cubist Systematic Strategies's biggest Q1 2022 reduction was Medtronic, cutting an estimated $35.7M.
  • Cubist Systematic Strategies fully exited Trine II Acquisition Corp. Units, each consisting of one Class A Ordinary Share and one-half of one redeemable warrant in Q1 2022, selling an estimated $20.6M.
  • Cubist Systematic Strategies's ten largest holdings make up 3.5% of its $11.8B portfolio in Q1 2022.
  • Cubist Systematic Strategies opened 613 new positions and closed 518 in Q1 2022.
  • Cubist Systematic Strategies's portfolio value rose 13% quarter-over-quarter to $11.8B.

Based on Cubist Systematic Strategies's 13F filing for Q1 2022, filed 16 May 2022.